Actively Recruiting
Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)
Led by Oslo University Hospital · Updated on 2024-02-16
81
Participants Needed
1
Research Sites
520 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare CXL with combined treatment with CXL and t-PTK. The main questions it aims to answer are whether combined treatment can give better visual acuity and if the treatments are equally safe.
CONDITIONS
Official Title
Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
- Progressive keratoconus with indication for CXL
- Corneal thickness 420 bcm
You will not qualify if you...
- Other eye disease causing visual impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Ophhtalmology, University of Oslo
Oslo, Norway
Actively Recruiting
Research Team
O
Olav Kristianslund, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here